Cost-of-Illness of Skin Cancer: A Systematic Review.

Annick Meertens Laura Van Coile Tijs Van Iseghem Lieve Brochez Nick Verhaeghe Isabelle Hoorens

Published in: PharmacoEconomics (2024)

A homogeneous skin cancer cost-of-illness study design would be beneficial to enhance between-studies comparability, identification of cost drivers, and support evidence-based decision-making for skin cancer.

Keyphrases

skin cancer
decision making
case control
bioinformatics analysis